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Abstract 
This chapter describes developments of infectious disease control in the dairy cattle industry, and 
outlines recent research in this area. A risk analysis approach is presented as a framework for 
managing infectious disease at global and farm level. Disease hazards, and the release and exposure 
of these are discussed. The importance of disease detection, the use of diagnostic tests, their 
appropriate interpretation and surveillance are highlighted. The range of impacts of infectious 
disease on the dairy industry is described and guidelines to estimate and evaluate risks of infectious 
diseases are provided. In addition, the challenges around successful implementation and effective 
communication of risk management on dairy farms are reviewed.  
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1. Introduction 
Animal tissues colonised with pathogenic organisms are said to be ‘infected’. This may evoke a host 
response in an attempt to remove the ‘causal’ agent. Associated clinical signs are sometimes, but 
not always, visible in the live animal. Commonly infection is subclinical, meaning no observable 
change occurs in the host, despite the potential for onward disease transmission. Infectious diseases 
in dairy cattle pose threats to food security, food safety, national economies, biodiversity and the 
rural environment. Challenges, such as climate change, regulatory developments, changes in the 
geographical concentration and size of livestock holdings, and increasing trade change the impact of 
dairy cattle diseases and the ways in which they can be controlled. New infections of environmental 
origin are inherently local, yet spread of infection between cattle can potentially be global. 
Responsibility for control may reside with governments or individual farmers, yet the principals of 
disease control are universal. 
 
This chapter starts by reviewing the impact of infectious disease. It then discusses basic principles of 
risk assessment and management before going to review some of the key steps: hazard and risk 
identification, followed by risk assessment and evaluation, and concluding with risk management. It 
also discusses the key role of effective communication, issues in ensuring effective implementation 
and trends in infectious disease control strategies. 
 
An example farm is used to illustrate some of the key issues in disease control. The farm is a 200 cow 
dairy herd in the UK. On this farm, producing 7,800 kg of milk per cow per year, the cows are housed 
from November to March and graze in the farms fields for the rest of the year. The herd calves all 
year round. The farm breeds its own replacements. Heifers are contract reared off-site from eight 
weeks of age, and return to the farm approximately 4 weeks before calving. A bull is bought 
approximately every 3 years to breed cows not pregnant after 3 to 6 AI attempts. The farm is 
surrounded by arable land on three sides, fields on the remaining side border an extensive beef and 
sheep farm. 
 
It is a family run farm, employing 2 casual workers during busy times. The farmer’s wife and children 
help out with milking on a regular basis. The farm uses a contract foot-trimmer and contractors 
assist with forage and slurry management. The farmer wants to expand to a 300 cow herd. The 
farmer’s business goal is to be most profitable by optimizing herd health and production. To stay 
informed, he reads the local farming press, and attends farmer discussion groups. A farm consultant 
visits monthly to discuss farm progress, mainly focussing on nutrition. An agricultural accountant 
visits monthly to discuss finance. A veterinarian visits the farm once a month for a routine visit, 
mainly focussing on fertility. The farmer is in need of time to organise and care for his elderly 
parents. The farmer’s eldest child is due to return from a year working on dairy farms in New 
Zealand, via a trip backpacking in South East Asia. 
 
The herd is currently tested for bTB every four years as part of a government programme. The farmer 
vaccinates breeding cattle against BVD following detection of BVD in youngstock three years 
previously. A quarterly bulk tank milk ELISA test is conducted to identify antibodies to IBR and 
Leptospira serovar Hardjo (Leptospirosis). The last four tests were low positive for IBR and negative 
for Leptospirosis. Individual cow milk ELISAs for MAP are carried out to meet milk buyer 
requirements. In the latest test report, six cows were identified as MAP-positive (following two 
consecutive positive ELISA results) and 10 cows were classified as ‘inconclusive’ (tested ELISA positive 
once). The farm is on monthly milk recording, and has basic data collection in place, including AI and 
treatment records that are entered into computer software. 
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2. The impact of infectious disease 
The impact of infectious diseases in dairy cattle need consideration in its full extent; this 
encompasses impacts on: 
- animal welfare 
- animal productivity 
- public health 
- trade 
- Society 
 
Each of these need attention when performing an impact assessment on an individual farm.  
 
The impact of infectious disease on animal welfare can present itself in direct and indirect ways. 
Dependent on the pathogen, animals can experience stress, pain and fear as a consequence of 
disease and its management. Indirectly, animal movement restrictions dictated by government 
disease control programs can lead to housing problems due to increasing stocking densities when 
animals cannot leave the farm. Slaughter programs in response to a disease outbreak need to assure 
a humane death for animals killed on the farm to ensure animal welfare. 
 
Animal diseases lead to mortality and reduced productivity in dairy herds worldwide, causing 
substantial economic losses. Diseases may affect dairy farm productivity through: 
 lowered milk yield 
 reduced milk quality 
 increased statutory or voluntary culling 
 increased adult cow mortality 
 reduced feed conversion 
 delayed age at first calving 
 reduced fertility 
 reduced weight gain 
 reduced market value 
Milk production can be profoundly reduced in cows with clinical disease. The duration of acute 
clinical syndromes can be short, but the effects of the disease may persist throughout the entire 
lactation (Archer et al., 2013). Disease during early lactation may reduce peak milk yields and 
therefore contribute to lower total lactation yields. The effects of disease on productivity can be 
direct (such as mastitis causing a profound reduction in milk yield) or indirect (IBR infection leading 
to reduced feed intake, thus causing reduced milk yield). The best documented direct effect is the 
effect of mastitis on milk yield. A single case of clinical mastitis can result in a milk yield loss of 300–
400 kg/lactation, with variations ranging from negligible to 1,050 kg. Mastitis during early lactation is 
associated with higher losses (450–550 kg) than cases seen later in lactation. Probabilistic sensitivity 
analysis carried out by Down et al. (2013) suggests that, when seeking to minimize the economic 
impact of clinical mastitis in dairy herds, great emphasis should be placed on the reduction of 
pathogen transmission from cows with clinical mastitis to uninfected cows. 
 
Production losses resulting from endemic disease can be considerable; a Canadian study 
investigating the effect of BVD, Neosporosis (N. caninum) and MAP demonstrated that cows in BVD-
seropositive herds had reductions in 305-day milk yield, fat, and protein of 368, 10.2, and 9.5 kg, 
respectively, compared with cows in BVD-seronegative herds. MAP-seropositivity was associated 
with lower 305-day milk yield of 212 kg in multiparous cows compared with MAP-seronegative 
multiparous cows. N. caninum seropositivity in primiparous cows was associated with lower 305-day 
milk yield, fat, and protein of 158, 5.5, and 3.3 kg, respectively, compared with N. caninum-
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seronegative primiparous cows (Tiwari et al.,2007). A follow-on study assessed the impact of MAP 
and found an average Canadian dairy herd lost CA$2992 annually due to MAP, or CA$49 per cow per 
year (Tiwari et al., 2008). A study to determine costs due to four endemic infectious diseases in 
Canada (MAP, BVD, N. caninum and EBL found total annual costs for an average, infected, 50 cow 
herd to be CA$2472 for MAP; CA$2421 for BVD; CA$2304 for N. caninum and CA$806 for EBL. A 
sensitivity analysis showed the largest effect on costs was due to the effect on milk yield (Chi et al., 
2002). 
 
Diseases that delay or prohibit oestrus expression or conception have a negative effect on herd 
productivity by prolonging the time cows spend in lower-producing stages of lactation, by reducing 
the number of offspring for replacements or for sale, and by increasing the likelihood the animal will 
be culled prematurely. For example, the likelihood of conception was reduced by 15% for cows that 
experienced metritis. A Canadian study demonstrated that EBL-seropositive cows had a higher risk 
of prolonged calving interval in first lactation cows compared with EBL-seronegative cows. N. 
caninum-seropositive cows had a 1.27 times higher odds of having a calving interval > 484 days 
compared to N. caninum-seronegative cows. Also, an interaction between N. caninum and BVD was 
observed with respect to first service to conception interval, with odds ratios of 0.64 and 1.06 for N. 
caninum-seropositive cows (compared to N. caninum-seronegative cows) in BVD-seronegative and 
BVD-seropositive herds, respectively (VanLeeuwen et al., 2010). 
 
In the dairy industry reduced weight gain is important when rearing heifers or bull calves. 
Unsurprisingly, studies have found that diseased animals gain weight more slowly than equivalent 
disease-free animals. Furthermore, diseased animals may have lower market value either due to 
visible lesions or indirect changes in appearance or body conformation which make them less 
attractive to buyers. True market value of final products may be altered due to changes in the ratio 
of meat to fat or to bone. The value of meat or offal from cull cows may also be reduced due to 
pathological changes caused by infectious pathogens such as Fasciola hepatica or Echinococcus 
granulosus. Presence of lesions of a zoonotic disease  renders the carcase partially or totally unfit for 
consumption. Generalised systemic illness may also lead to condemnation of an entire carcase. 
Diseases which affect the skin, such as warble fly infestation may reduce the market value of hides. 
The costs of culling can be offset by a financial return if the animal can enter the food chain. 
Voluntary culling is part of a cost effective herd replacement strategy, whereas involuntary culling is 
undesirable. An inadequate replacement strategy can leave an empty cubicle space on the farm 
which increases fixed costs per litre of milk produced. The two most important services provided by 
cattle in the developing countries are traction and manure production, and disease may reduce the 
supply of both of these. 
 
Many dairy cattle production diseases do not result in death, but reduce the production efficiency. A 
large proportion of cattle that are culled from a dairy herd are considered involuntary culls (driven 
by disease or injury) rather than for reasons of low production. The premature removal of a cow 
from the herd reduces her lifetime milk yield and incurs disposal costs for the carcase. The impact of 
a disease on productivity is dependent on many others factors such as exposure of the pathogen 
involved; introduction of the same pathogen into a naïve herd will have much greater impact 
compared to the transmission of this pathogen already present in the herd. Factors such as these 
make it difficult to draw sweeping conclusions with regards to the cost of disease on a farm, 
although some of the referenced studies give an indication of potential effects of pathogens on 
productivity. It remains crucial for veterinarians to discuss potential productivity losses with their 
client on an individual farm basis. 
 
Approximately 75% of recent emerging human diseases have emerged from an animal source. The 
route to exposure to infectious pathogens is different between developed and developing countries; 
5 
 
in the UK the use of unpasteurised milk is gaining popularity within certain parts of the population, 
increasing the risk of disease although pasteurised products are widely available. Human health 
risks, such as Lyme disease (2000 human cases/year in the UK) or E.coli at farm visitor attractions 
highlight the tension between recreational and productive use of the countryside. Other examples of 
zoonotic diseases which have substantial health impacts on the human population are BSE, Q-fever 
(Coxiella burnetti) (Porter et al., 2011) and Brucellosis. In developing countries the route to exposure 
is more difficult to control due to intensive contact between pastoral farmers and their cattle, and 
the limited opportunities to improve food safety, such as pasteurization. A livestock-human 
brucellosis transmission model (Zinsstag et al., 2005) was linked to a livestock productivity analysis 
to evaluate the impact of a planned 10-year livestock mass vaccination campaign to determine the 
cost-effectiveness, expressed as cost per DALY (disability adjusted life year) averted. The conclusion 
was that if the costs of livestock vaccination were allocated to all sectors in proportion to the 
benefits, the intervention might be profitable and cost effective for the agricultural and health 
sectors (Roth et al., 2003).  
 
Particularly in developing countries the major effect of animal disease on human wellbeing is 
through a reduced supply of high quality protein, which means a reduced supply of milk for young 
children. Cattle products are also important sources of other nutrients, notably minerals and 
vitamins, and diseases can both reduce the total supply of animal products and modify the 
composition of animal products in ways which reduce their nutritional value. 
 
Even for infectious diseases of primarily viral origin, such as bovine respiratory disease, 
antimicrobials are often used as treatment, since secondary bacterial pathogens may be involved. 
Whilst there is currently limited evidence that the use of antimicrobials in farm animals is a 
significant contributor to the development of antimicrobial resistance in the human population, 
there is significant public interest in the prudent use of antimicrobials in veterinary medicine, and 
veterinarians must prescribe responsibly if this privilege is to remain. To this end, reliance on 
treatment with antimicrobials is unlikely to be sustainable; therefore, the control and prevention of 
infectious disease in cattle is paramount. 
 
The occurrence of trade-restricting diseases impact both livestock farmers in the developed and 
developing world by marginalizing them from higher-price livestock markets and restricting their 
capacity for value-added trade. The global epidemiology of FMD is almost a mirror image of the 
global economic structure: 
 FMD-free group: equivalent to high-income, industrialized zones 
 FMD control regions: mainly middle-income, semi-industrialized countries characterized by 
medium to high FMD-control activity; South America is the most prominent of these regions 
 FMD endemic group: generally among the least-developed countries, some of which have a high 
livestock density 
The socio-economic trade effects of disease and subsequent disproportional government support at 
a national level in the developed world are illustrated by the FMD outbreak in the UK in 2001: a 3 
billion GBP loss was estimated for the public sector and 5 billion GBP to the private sector, and 
losses on tourism and local businesses were larger than losses to farming. However, culled-out 
farmers received financial compensation whereas small rural businesses did not. 
 
The effect of an export ban can be significant in developed as well as developing countries. For 
example, for Somalia, a significant and longstanding exporter of live animals to Kenya and the Gulf 
region, the effect of an export ban of cattle in 1998-2000 due to Rift Valley Fever was devastating; 
exports decreased by 2 million head which equated to approximately US$100 million to individuals 
and communities in the region. During the ban, it was estimated that the price of cattle fell by 65%. 
In terms of absolute loss of income, the poor were less affected since they sell fewer numbers of 
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animals, but they probably endured greater hardship than the rich because the ban prevented them 
from selling the few animals they need to sell to survive. 
 
At the farm level trade can also be impeded by infectious diseases due to its effect on the value of its 
produce; a high SCC in milk will be penalized by the milk processor, who will pay less or will refuse to 
process the milk. Milk from cattle treated with antimicrobials cannot be sold into the food chain 
during the milk withdrawal period, and the presence of infectious disease on the farm will reduce 
the likelihood of farmers to sell stock or produce.  
 
In the UK, BSE damaged public confidence in food safety and undermined the food industry and 
British agriculture which faced a decade-long ban on beef exports. In addition, the government’s lack 
of transparency, its handling of the scientific uncertainty that had surrounded BSE aetiology and 
government promotion of the interests of farmers over the public interest, severely damaged public 
trust in policy making. Efforts to harmonize trade within the European Union and to reform the 
common agricultural policy by reducing international trading barriers has led to an increase in the 
scale and frequency of international livestock movements, and the reappearance of FMD in several 
countries that were formerly free of the disease (Woods, 2011).  
 
Infectious disease outbreaks, such as FMD, Bluetongue and bTB, emphasize that maintenance of a 
‘disease-free’ status when the disease occurs elsewhere is risky and difficult to control. A 
collaborative effort in supporting developing countries or other farmers to control infectious disease 
will benefit others already free from disease. Political support is present in some cases but is 
sometimes hampered by the economic advantage a ‘disease-free’ country has over not ‘disease-
free’ countries when exporting their produce. 
 
Particularly in developing countries animals serve functions far beyond utilitarian roles. While these 
are not strictly economic in nature, they are vital functions which should be included in any 
consideration of the significance of animal disease. Livestock sales are instrumental for expenditures 
such as school fees, to support development of their children via education. 
 
How would the impact assessment apply to our example farm? 
It is difficult to assess the effect of one infectious disease on productivity but the knowledge that BVD 
is present make it likely that reproductive and youngstock health performance would increase when 
this disease is eradicated. If BVD were eradicated, biosecurity precautions should be stepped up to 
minimize the risk of reintroducing disease, and costed into the programme. It is important to 
investigate culling rates on the farm, as they may be increased due to infectious disease. 
 
With the cattle industry supporting BVD eradication in the UK it is important to consider the decrease 
in market value an animal from this farm may have. In Europe, milk processors and retailers are 
becoming more involved in quality control of their products and the consequences this may have on 
this farm where endemic disease are present is worth discussing with the farmer. 
Because the farmer is considering selling heifers abroad, it is important to review export 
requirements, where often a negative antibody test is required to permit export. Also the use of 
vaccines is often not permitted, as it interferes with the detection of naturally acquired antibodies. 
Marker vaccines are available for IBR to facilitate international trade of cattle. 
 
Social influences are often unmentioned but can be important drivers for farmers to control diseases 
such as BVD. They often want to be perceived as ‘good’ farmers, and their cattle being disease-free 
contributes to that. 
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3. Principles of risk analysis and management 
 
Infectious agents can transmit to susceptible cattle through a variety routes, particularly when 
population density is high, resistance is compromised, or pathogens are particularly virulent. Many 
infectious agents can survive in the environment, and this reservoir can overwhelm host defences if 
hygiene is poor. We acknowledge the importance of maintaining environmental hygiene and animal 
immunity through adequate nutrition and husbandry, but focus this Chapter on the principals of 
reducing the risk of infectious pathogen transmission by applying a risk analysis approach (Figure 1) 
using the OIE and FAO framework (FAO, 2016). Hazard identification is the process of identifying the 
pathogenic agents which could potentially be introduced. Risk assessment is the evaluation of the 
likelihood and the biological and economic consequences of entry, establishment or spread of a 
pathogenic agent. Risk management is the process of identifying, selecting and implementing 
measures that can be applied to reduce the level of risk. Risk communication is the interactive 
exchange of information on risk among risk assessors, risk managers and other interested parties. 
 
Figure 1. The four components of risk analysis 
 
 
 
 
An infectious disease is controlled when the incidence rate at which new cases occur in susceptible 
individuals is less than the rate at which infected individuals are removed, by recovery or death of 
the animal. The threshold for many epidemiology models is the basic reproduction number R0, which 
is defined as the average number of secondary infections produced when one infected individual is 
introduced into a host population where everyone is susceptible. For many epidemiology models, an 
infection can get started in a fully susceptible population if and only if R>1. Thus the basic 
reproduction number R
 
is often considered as the threshold quantity that determines when an 
infection can invade and persist in a new host population.  
Endemic diseases occur at a steady state in a population, measured by the prevalence, the 
proportion of individuals infected. An important concept in infectious disease management is to 
determine an acceptable prevalence on economic and welfare grounds. For some diseases that are 
considered exotic, any presence is unacceptable. Eradication is a special case of control where active 
measures are taken to eliminate disease. 
 
Managing infectious disease incurs a cost and the consequences of infectious disease are also costly. 
This infectious disease cost is often difficult to comprehend; as insidious production losses may be 
challenging to demonstrate. Risk analysis is a process to balance the costs of disease control with the 
costs of the consequences, in order to aid decision making around infectious disease management. 
The use of the risk analysis framework will demonstrate the logic of the steps involved, and highlight 
the complexities when managing endemic infectious diseases. 
Hazard 
Identification 
Risk 
Assessment 
Risk 
Management 
Risk Communication 
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4. Hazard and risk identification 
Hazards are items that may cause harm. In the context of infectious diseases, these are the causal 
pathogens themselves. It is important to appreciate the difference between risks and hazards. 
Hazards can cause harm, conditional on other events. Risks are a measure of how likely it is that 
harm will occur in a particular circumstance. For example, IBR-virus is a hazard for a naïve herd, but 
may only become a significant risk if a farmer plans to purchase replacement heifers from an IBR-
positive herd or one of unknown health status.  
 
A non-exhaustive list of hazards that could cause harm to cattle is provided in Table 1. It is beyond 
the remit of this Chapter to discuss the specific biology of each infectious pathogen. However, it is 
acknowledged that it is crucial to have a thorough understanding of the pathogen, and specific 
recommendations are provided in the Resource section at the end of this Chapter. 
 
Table 1. Examples of (genus level) infectious hazards to dairy cattle. Zoonotic pathogens are 
indicated in red, OIE listed diseases (OIE, 2016a) are indicated with ‘(L)’ and the, according to the 
authors’ opinion, more significant pathogens for dairy cattle are printed in bold. Further information 
regarding these pathogens can be found in the Resources section of this Chapter. 
Gram 
negative 
bacteria 
Gram 
positive 
bacteria 
Viruses Parasites & 
Protozoa 
Funghi Other 
Aeromonas Aerococcus Aujesky’s 
Disease (L) 
Ascaris Trichophyto
n 
Prions (Bovine 
spongiform 
encephalopatht
y, L) 
Acinetobacte
r 
Bacillus (L) Bluetongue (L) Babesia (L) Rhinosporidi
a 
Mycoplasma 
(Contagious 
bovine 
pleuropneumon
ia, L) 
Actinobacillu
s 
Clostridia Bovine Herpes 
Virus (L) 
Bunostomum Rhizopus Ureaplasma 
Brucella (L) Corynebacter
ia 
Bovine 
immunodeficie
ncy  
Cryptosporidia Prototheca  
Campylobact
er (L) 
Enterococcus Bovine Viral 
Diarrhoea (L) 
Dictyocaulus Mucor  
Citrobacta Erysipelothrix Corona  Eimeria Mortierella  
Chlamydia Listeria Cow pox  Fasciola Histoplasma  
Coliforms Micrococcus Foot and 
Mouth Disease 
(L) 
Giardia Entomoptho
ra 
 
Dichelobacte
r 
Mycobacteri
a (Bovine 
tuberculosis, 
L) 
Lumpy skin 
disease (L) 
Haemonchus Candida  
Fusobacteriu
m 
Staphylococc
us 
(Para) Influenza Ostertagia Aspergillus  
Haemophilus Streptococcu
s 
Rabies (L) Paramphistom
um 
Absidia  
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Leptospira  Respiratory 
syncytial virus 
Sarcocystis   
Moraxella  Rift Valley 
Fever (L) 
Schistosoma   
Neisseria  Rotavirus Stephanurus   
Pasteurella 
(Haemorrhag
ic 
septicaemia, 
N) 
 Rinderpest (L) Strongyloides   
Prevotella  Schmallenberg Toxoplasma   
Rickettsia 
(Heartwater, 
L) 
 Vesicular 
stomatitis 
Trichomonas 
(L) 
  
Salmonella  Enzootic bovine 
leukosis (L) 
Trypanosomas 
(L) 
  
Treponema   Anaplasma (L)   
Yersinia   Theileria (L)   
Coxiella 
burnetii (L) 
  Echinococcus 
(L) 
  
 
 
In the case of each hazard, there are a number of factors affecting its release into the environment 
to cause harm. It is well established that cattle farms are often unique in respect to disease control 
(LeBlanc et al., 2006). Profound variation in release risks can be found at the level of neighbouring 
farms, because of different management methods present on the farm (i.e. artificial insemination 
versus natural mating). In the case of endemic diseases this is complicated by the fact that the 
release of a pathogen signifies a different risk on different farms; i.e. the release of IBR on a farm 
where IBR is endemically present has moderate consequences compared to the release of the same 
virus in a naïve herd. 
 
Climate change, increased world trade and human travel are only some of the factors which need to 
be considered when identifying release risks. A consequence of the ongoing globalisation of livestock 
production, animal feed and food supply is that the release risk is increasingly difficult to manage 
(Bioportal FAO, 2011). These issues are augmented by the increasing spread of vector-borne 
diseases and zoonoses internationally; this is considered to be due to climate change and altered 
land usage along with other factors (Kilpatrick and Randolph, 2012). Table 2 lists release factors of 
infectious disease on a dairy farm. 
 
Table 2. Examples of release factors of infectious disease and details of the associated release 
mechanisms. 
Release factor Potential risks 
Livestock on site  Inadequate age separation, isolation of sick animals, cross species contact  
Livestock off site  Inadequate biosecurity of neighbours, shows, sales, markets, AI, embryos 
Machinery Sharing with other farms, inadequate biosecurity – vets, foot trimmers, 
collections - tankers, fallen stock, hauliers  
Feed Potential contamination of feed, source of feed, feed stations – gathering of 
stock  
Water Shared water courses, ponds, watering holes, water stations 
Wildlife Birds, mammals 
Humans Zoonotic disease, contact with more than one site 
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Vectors Insects, vaccines, semen, embryos  
 
 
5. Risk assessment and evaluation 
 
Risk assessment is a systematic process of evaluating the potential risks that may be involved in 
contracting an infectious disease. The identification of hazards as sources of risk and the release 
mechanisms of infectious disease have been discussed in the previous section. The animal’s immune 
system may be capable of protecting the animal against clinical disease and influence its disease 
susceptibility. The exposure risk for infectious agents affecting dairy cattle differs markedly 
throughout the world. To identify exposure, we need to focus on the role of disease detection and 
surveillance. 
 
5.1 Detection 
The OIE has promoted the rapid development of biotechnology, informatics and information 
systems (OIE, 2016). Biotechnology encompasses the diagnostic fields utilising materials such as 
nucleic acid and proteins in tests. Tests identifying specific proteins can detect antigen being present 
in the animal or ascertain an antibody response, indicating the animal has been exposed to the 
pathogen at some point. Whilst conventional methods are not to be dismissed the future is aimed at 
high throughput, automated systems with reduced margins of error (OIE, 2015). Techniques such as 
metabiomics, genomics and proteomics are developed to further our ability to identify pathogens 
and understand their epidemiology. Cow side tests using lateral flow technology, microarrays to 
screen for multiple pathogens (Shallom et al., 2011) or optical densities measured on mobile phones 
are all technologies being developed. 
 
It is essential to consider the test characteristics when interpreting the results; i.e. sensitivity, 
specificity and predictive values (Table 3, Dufour and Hendrix, 2009). The aspiration for any test is to 
be 100% accurate, but this is an unachievable goal.  
 
Table 3. Definitions important when interpreting test results. 
Term Explanation 
Sensitivity The proportion of infected animals testing positive 
Specificity The proportion of non-infected animals testing negative 
Positive predictive value Probability that the animal / herd is diseased, given a positive result 
Negative predictive value Probability that the animal / herd is not diseased, given a negative 
result 
 
The practicalities of carrying out the test may yield false-positive or false-negative results, due to 
reasons such as an error in reporting or cross-reaction of antibodies. The circumstances in which the 
test is being used is important too; the outcome of a test may depend on the stage of disease, i.e. it 
may take 3 weeks after exposure for an animal to have a detectable antibody response. Confidence 
in the sensitivity, specificity and predictive value of a test should be held up to question, particularly 
if anomalous results are produced. Repeating a test or using an additional test using a different 
methodology can improve reliability of the aggregated test outcome. 
 
Effective sampling is as important as selecting the right kind of test. Determining the number of 
samples to take is dependent on the suspected prevalence of the disease (Naing et al., 2006). There 
is an array of formulae available within the literature to provide guidelines for sample collection 
(Rothmans et al., 2008). For demonstration of freedom from disease, output based surveillance can 
improve the efficacy of surveillance, which uses a risk-based sampling strategy (Cameron, 2012).  
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Access to laboratories and diagnostic tests varies worldwide; contacting government veterinarians, 
universities, pharmaceutical companies or commercial diagnostic laboratories is recommended for 
detailed information regarding the best way forward when detecting disease in a specific part of the 
world. A good understanding of the disease, the farm history and the aim of testing is required to 
select the most appropriate test methodology. 
 
The example farm is assessing MAP infection by means of ELISA testing. In conjunction to this, there 
is a national policy of skin testing in place to eradicate bTB. This is relevant, as the skin test used for 
bTB may produce false positive results in MAP ELISA tests for at least one month post skin testing; 
MAP ELISA testing would therefore not be advised in that time frame. If MAP testing within a month 
after bTB testing unavoidable, it is advised that positive MAP ELISA results should be confirmed by 
additional test methodologies, such as PCR or bacterial culture. 
 
If we were to use a MAP antibody ELISA on milk with a sensitivity in a healthy animal of 40% and a 
specificity of 95%, the positive predictive value of a single positive test result, if the herd has a 
prevalence of 10%, is only 47%.  If the prevalence was 1% the positive predictive value would only be 
8%; even when specificity is high, in low prevalence herds false positives results become relatively 
common. Using a faecal PCR with a sensitivity of 35% and specificity of 99% results in a positive 
predictive value of 80% and 26% in a 10% and 1% prevalence herd respectively. The seemingly small 
difference in specificity makes a large difference to the PPV in low prevalence herds. 
 
5.2 Surveillance 
For on-farm monitoring the recording of data and adequate interpretation is crucial in identifying 
whether infectious disease is present. As samples to collect for monitoring infectious diseases one 
should consider: 
 Clinical assessment of the herd (e.g. FMD) 
 (Bulk) milk samples for antigen or antibody (e.g. IBR) 
 Blood samples (e.g. Leptospirosis) 
 Fecal samples (individual or composite slurry) (e.g. Salmonellosis) 
 Post mortem adult cattle, abattoir findings (e.g. Fasciola hepatica) 
 Aborted fetus and placenta for post mortem investigation (e.g. N. caninum) 
 Earnotch skin samples (e.g. BVD) 
 Fertility and production performance data (to support other diagnostic findings and monitor 
overall herd performance) 
The local diagnostic laboratory needs to be contacted for further advice on interpretation of test 
results as much depends on test methodology, local circumstances but also the reason for 
monitoring; are you aiming to control an endemic disease, or maintaining a herd free of disease? 
Monitoring at herd level is also important when a farm is free of disease, as historical information 
can help identify a possible causal relationship when positive test results are obtained. 
 
The development and maintenance of disease surveillance programmes for infectious diseases in 
dairy cattle requires a robust veterinary service (Vial and Berezowski, 2015). This requires national 
and international input with guidance from FAO, OIE and other parties (Yassif et al., 2013). At a 
global level, the OIE, FAO and WHO all contribute to the Animal Health Yearbook to report the 
disease status of each organisations’ member countries. The monitoring and exchange of disease 
information that is consistent, reliable and usable is vital to all countries. In the case of a zoonotic 
condition then the WHO is also incorporated into the process.  
 
The evolution of a virtual surveillance network demonstrates there is a drive to deliver this 
surveillance using modern techniques and methods (NAHSS, 2014; UK Virtual Surveillance Network, 
2011). However, even the most advanced biosecurity systems cannot negate all risk of exposure to 
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disease. As well as monitoring of disease to enhance disease control efforts, surveillance data is 
useful for research. Surveillance is best described in terms of the three objectives it seeks to deliver: 
disease detection, facilitation of the response and, finally, communication of risk. 
 
The surveillance response can manifest itself in various ways, ranging from cattle products export 
bans at national level to culling infected cattle, vaccination or treatment at the individual animal 
level. The response is dependent on the type of disease detected; a response to notifiable or 
reportable diseases will be decided upon by government, while in endemic diseases the response 
can be guided by control schemes developed by stakeholders or can be left to the individual farmer 
to respond to. When identifying emerging diseases, a collaboration between government and 
industry is helpful to support knowledge development of the pathogen involved and implement an 
adequate response. The delivery of an effective response is particularly challenging on a global 
stage. Table 4 highlights limiting factors influencing response ability at a global level. 
 
Table 4. Limiting factors influencing international response in disease surveillance. 
Ranking Factors limiting international response 
1  Quality of national surveillance 
2 Data standards for reporting 
3  Wildlife surveillance data 
4  Cooperation between international parties 
5 Data sharing between stakeholders 
6 Data storage formats 
7 Laboratory capability variation  
8 Funding for surveillance 
9 Training in surveillance 
 
The potential benefits of robust surveillance can be seen in those Northern European countries 
which are officially free of several infectious diseases, including Leptospirosis, EBL, and bTB, and 
have strong control programs in place for MAP, IBR, BVD, Salmonellosis and Neosporosis. This 
tremendous achievement is largely attributed to routine practices of requesting diagnostic test 
results when purchasing cattle, embryos, or semen, and the use of milk-based tests for monitoring 
herds for diseases with substantial deleterious effects on production and longevity. 
 
How does disease surveillance apply to our example farm? 
The farm is taking quarterly bulk milk samples to monitor the herd’s disease status, this provides 
evidence of the disease having been or being present in the herd. A positive result for IBR and 
Leptospirosis is worth evaluating; what is reproductive performance like in the herd, as both IBR and 
Leptospirosis can affect this. When the performance appears suboptimal, or when there are other 
drivers to undertake control (selling heifers abroad), steps can be taken to control these diseases. 
Continued monitoring using bulk milk is beneficial to remain informed; having access to historical 
data can help to explain future events, as a decrease in antibody titres for IBR or Leptospirosis would 
support successful control. On the other hand, a sudden rise in N. caninum antibodies coinciding with 
clinical abortion, would support a N. caninum diagnosis. Monitoring for government controlled 
diseases is minimal in the UK; bovine abortions need to be reported for Brucella surveillance and 
Brucella is also monitored via central bulk milk collection. The industry is promoting a BVD-free 
campaign and knowing this farm has been exposed to BVD previously and is currently vaccinating, it 
is worth discussing control measures, as participating in a national approach could be of value. 
 
5.3 Risk estimation and evaluation 
Risk estimation is a way to summarise the risk assessment stages; release, exposure and impact. 
Where quantitative data are available, risk estimation is the product of these items and can give a 
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monetary value for a disease. However, where the framework of risk analysis is used on an individual 
farm, and numerical data are lacking, a qualitative risk estimate is still useful for each disease. This is 
best understood by considering specific scenarios provided in the example below. 
  
The goal of risk evaluation is to identify what action, if any, is appropriate to mitigate the risk for a 
specific disease for the farm or group of cattle on the farm, region or a country in question. The 
result of the risk evaluation will inform the control options that are considered and subsequently 
implemented. There is frequently a large degree of uncertainty around risk evaluation. Efforts to 
quantify that uncertainty to facilitate decision making regarding further action are challenging. For 
example, the UK government published a quantitative risk assessment of Bluetongue virus incursion 
from central Europe based on weather forecasting and proximity of disease to the English Channel. 
Although a quantitative risk of 5-10% for May 2016 was presented, this result did not clarify if and 
what control measures needed to be put in place for an individual farm (DEFRA, 2016). 
 
At any given time a farm will be facing a number of infectious disease risks, as well as production 
limiting non-infectious diseases (i.e. ketosis, displaced abomasa, dystocia) and other challenges (i.e. 
limited feed supply, insufficient labour, trade restrictions) and the risk evaluation of a specific 
infectious disease will depend on ongoing other issues and the priorities of the farmer. Risk 
evaluation is heavily influenced by the risk behaviour of individuals involved, both farmers and their 
advisors. For example, one farmer may consider a potential risk (such as having cattle affected with 
clostridial disease) acceptable if it saves time and money, whereas another farmer may prefer to 
avoid this risk at all cost (and use vaccination to reduce the risk of disease). Evaluating these 
personal aspects is important and emphasizes the need for a tailored infectious disease control plan. 
 
Our example herd has some evidence of IBR presence, but not Leptospirosis based on bulk milk 
antibody testing. The farm is embarking on an expansion programme; this has been funded by a 
bank loan, and the bank manager is keen to see a return on the investment in terms of more milk 
being sold to repay the loan. For the first time in the farmer’s lifetime he needs to buy in cattle. With 
IBR already present in the herd, the consequences of purchasing infected cattle were considered 
negligible, regardless of release and exposure risk if heifers were sourced from a herd of similar 
health status. However, there was a lot of uncertainty in the risk estimate due to infrequent testing 
of bulk milk, since this only considers milking cows at a given point in time. 
 
Given that pressure from the bank manager was more influential than pressure from the 
veterinarian, the farmer deemed the risk of adverse consequences due to an IBR outbreak were less 
of a risk than having the farm repossessed and so purchased cows at a local farm sale. However, this 
herd was going out of business as the farmer had become ill with persistent headaches and had been 
diagnosed with Leptospirosis. Testing of the bulk milk showed high titres. These were low in our 
example herd. Buying cattle from the infected herd was deemed to create a high risk of Leptospirosis 
release and exposure, with severe consequences in terms of potential litigation from staff it they 
became ill in addition to potential for abortions and milk drop in his herd. A vaccination programme 
for Leptospirosis was commenced immediately, although it was not practical to isolate and treat the 
incoming cattle as recommended by the veterinarian. Therefore surveillance measures were stepped 
up and heifer cohorts and the bull were blood sampled for serology before vaccinating. This was put 
in place instead of bulk milk titres, which became positive due to vaccination. An exit strategy for 
vaccine use was discussed, but since the neighbouring sheep grazed the fields in winter, it was 
decided that the disease would probably not die out completely, and vaccination would continue as 
long as that risk was present. 
 
Our example farm highlights several reasons for choosing to control infectious diseases. bTB 
surveillance is being carried out by the government. The farmer is also relying on government border 
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controls to prevent the introduction of exotic diseases from their travelling son, for example in meat 
contaminated with FMD from South East Asia. The surveillance for MAP is paid for by the farmer but 
has a clear economic incentive – to maintain the milk buyer contract. Whilst there is limited choice in 
whether to control these risks, the farmer is able to evaluate the risk of other diseases and decide 
whether they warrant control on his farm. BVD vaccination has been triggered by the detection of 
disease on the farm. In contrast for IBR, the farmer has evaluated the risk and chosen not to 
vaccinate, despite evidence of exposure being present. This decision reflects the absence of an 
apparent problem, resulting in a decision to save money. Finally, the risk estimation has identified 
Leptospirosis as a potential risk, given the herd appears to be currently naïve; evaluating the risk 
would focus on the production and human health risks associated with this disease. 
 
6. Risk management 
Control options on a farm can broadly be grouped in to those where the focus is on preventing a 
new disease entering a farm (biosecurity), preventing further transmission of a disease already 
present on the farm (biocontainment) and increasing the cure rate or limiting the effects of disease 
(i.e. managing endemic disease). 
 
6.1 Preventative measures  
The complexity and rigour of the control measures as suggested in Table 5 will vary depending on for 
example the degree of risk reduction that is required and the resources that are available. A practical 
approach to reduce the risks of entry of diseases should focus on those routes of entry that are 
considered most likely. 
 
Table 5. Example measures to reduce the risk of infectious disease entering a farm (biosecurity 
measures). 
Route of infection Biosecurity measure Notes 
Infected cattle on the farm Operate a “closed” herd – 
introduce no new cattle to the 
farm 
This can be a very effective 
technique but does not suit 
all farm management 
systems. Care needs to be 
taken when using this 
system that no new animals 
are purchased including, for 
example, a stock bull 
 Source cattle from herd known to 
be free of the disease in question 
When animals are 
purchased, sourcing from a 
herd of known status can be 
helpful where they are 
available. Where this is 
carried out, ensuring the 
(high sensitivity) testing 
regime carried out to 
determine the disease status 
is appropriate is important 
 Isolate and test any purchased 
animals 
Quarantining incoming 
animals is regularly 
advocated and yet is almost 
impossible to achieve in 
adult dairy cows. Where 
testing is carried out this 
should be performed before 
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purchase. 
 Vaccinate existing and/or 
incoming animals 
While often carried out to 
limit the impact of disease, 
vaccination may also be able 
to prevent a disease 
incursion by reducing the 
susceptibility of animals to 
infection 
 Treat any animals leaving and 
returning to the holding as new 
animals 
Animals that are reared off 
site or taken to livestock 
shows must be treated as 
incoming animals and a full 
risk assessment carried out 
Infected cattle off the farm Maintain farm borders, ensure 
double fencing to limit physical 
contact with neighbouring cattle 
This is much easier to 
achieve in housed cattle and 
is not possible in all grazing 
systems, however strategic 
targeting of known risk areas 
can be used. 
 Do not spread slurry or use 
recycled manure solids from other 
farms 
Deliberate spreading of 
manure from other livestock 
can be avoided, shared 
grazing and watercourses 
may also represent a risk of 
transmission of pathogens 
Fomite transmission Minimise the number of visitors 
to the farm (ideally a separate 
entrance should be provided for 
non-farm visitors not visiting 
livestock areas) 
There are often visitors on 
farms, only those where 
access to livestock areas is 
essential should be granted 
such access 
 Provide suitable disinfection 
facilities and protective clothing 
for visitors to the farm 
This is particularly important 
for those that will have 
handled other livestock, for 
example contract farm 
workers, veterinarians and 
relief milkers 
 Minimise sharing of equipment 
with other farms, disinfecting 
thoroughly where shared 
equipment is needed 
Not all farms will be able to 
invest in their own 
equipment, where 
equipment is shared, 
particularly equipment used 
in livestock areas, this 
should be thoroughly 
disinfected. 
 Specific areas should be available 
for delivery vehicles and 
disinfection facilities should be 
available for vehicles and drivers 
Dairy farms will have high 
numbers of vehicles visiting 
to collect milk and deliver 
feed amongst other thing, 
ideally these vehicles should 
not enter livestock areas and 
should be disinfected 
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Feed and water Feed and water quality should be 
monitored and maintained with 
appropriate storage 
Feed and water can become 
contaminated with 
infectious diseases. Care 
should be taken when 
sourcing feed and water and 
control should be in place to 
prevent contamination once 
stored on the farm 
Other species Minimise exposure to wildlife and 
other domestic animals 
Eliminating all wildlife access 
to farms is problematic, 
having pest control measure 
in place and using fences, 
raising feed trough etc. may 
reduce the contact with 
cattle 
 
Where it is necessary to bring new animals on to a farm, determining the health status of a source 
herd can be challenging; methods vary from a verbal declaration by the seller through to evidence of 
serial testing for freedom of disease over several years. Once replacement animals have been 
sourced, and particularly when their health status is unknown a quarantine facility can be used. 
Quarantine can serve both to protect existing cattle from bought-in diseases as well as isolating new 
cattle from endemic diseases until vaccination has provided sufficient protection. A good 
understanding of the biology of the specific pathogen is essential. Quarantine of incoming cattle can 
be challenging when cows are lactating due to the need to use shared milking facilities. Non-
lactating pregnant cattle can also pose a risk with the in utero infected foetus being a potential 
source of infection once born, for example for BVD. Buying youngstock, whilst not risk free, is often 
the most biosecure but may not meet the needs of the buyer. A comprehensive review of applying 
this risk assessment process to the sourcing of new dairy animals is given by Maunsell and Donovan 
(2008). 
 
In many developed countries there is a stark contrast between the barrier measures taken on dairy 
farms compared to pig and poultry farms. Control options established in those farms can be 
applicable to dairy farms as well, but not as often implemented. The impact of disease exposure, 
small economic margins, government subsidy support, and cultural history of each industry type may 
explain some of the differences. The risks posed by essential visitors or borrowed machinery on a 
dairy farm can be reduced by the careful use of disinfectants as well as physical cleaning and good 
hygiene. It is essential to establish that the product used is active against the pathogens of concern 
(DEFRA, 2016) and manufacturers’ guidelines regarding appropriate dilutions and contact times are 
followed. Assuring compliance is important as for example the presence of an inappropriately 
formulated disinfectant footbath can provide a false sense of security. It is worth noting the use of 
non-chemical approaches to disinfection, such as drying and or ultra-violet radiation. 
 
As well as reducing the risk of entry of diseases on to a farm, an alternative or complementary action 
is to reduce the severity of the consequences of disease entry. This may be a biological strategy, for 
example using vaccination to limit the impact or an economic strategy such as insuring the herd 
against a specific disease risk. At a national level, strategies might be based on limiting the risk of 
further spread of the disease, for example by depopulation in cases of highly contagious diseases 
such as FMD. 
 
On our example farm vaccination is being used to limit the risk of exposure. For example, the farm 
may not be prepared to leave the grazing bordering the neighbouring farm unused. Accepting that 
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this may leave risk of exposure to BVD, the farmer has chosen to partially offset this risk by limiting 
the impact a disease incursion could have by vaccinating the herd. 
 
The major risk to control is the risk of bringing disease in with either the heifers or the bull. In this 
instance, the farmer is not willing to change the management of the farm, therefore control 
measures should be put in place to limit this risk. For example, when sourcing the bull, the farmer 
should have bought one from a Leptospirosis free farm. If unsure about the status the purchased bull 
could be treated and vaccinated against Leptospirosis, even though Leptospirosis is not present on 
the farm. Ensuring heifers complete the herd’s BVD vaccination protocol before coming onto the farm 
will be beneficial to protect them against diseases (sub)clinically present on the farm.  
 
The other areas of risk are less likely sources of disease but can be controlled at relatively little cost. 
For example, the risk posed by the casual workers could be reduced by making them aware of the 
biosecurity measures to adhere to on the farm and by providing a set of boots and overalls for use on 
this farm only. 
 
6.2 Controlling the risk from existing disease 
Controlling infectious disease in dairy herds also involves the control of those diseases already 
present in the herd, or those diseases where prevention of entry is not achievable. In these cases the 
focus of control should shift to biocontainment, where steps are taken to reduce the risk of 
transmission of the infectious disease between animals or groups of animals in the herd. Example 
strategies can include separating infected animals from uninfected and susceptible animals; this can 
be impractical if both groups of animals are in the adult milking herd, but can be more easily 
achieved if, for example for MAP, the at-risk animals are youngstock and the infectious animals are 
adults.  
 
Care should be taken that all potential sources of infection are identified; for example, a disinfectant 
footbath by the calf housing to prevent disease transmission from adult cattle to young stock may be 
of limited use if slurry from the adult milking herd drains through the calf accommodation. The risk 
of shared equipment and disease spread by staff on the farm also needs to be considered. When the 
preferred biocontainment measures are not possible, the next best option should be considered; for 
example, separate equipment for infected and susceptible animals may be preferred, but when this 
is not feasible, consideration should be given to appropriate disinfection of equipment. 
 
Other options for controlling spread within a herd are either treating or culling infected animals. 
Where treatment eliminates the infectious organism this can form an effective means of control, for 
example in cattle infected with Leptospirosis, treatment with streptomycin is used to reduce the 
chance of subclinical renal carriage and subsequent shedding in urine. Where elimination of the 
pathogen from the infected cattle is not possible the infected animals can be culled from the herd, 
either immediately (for example with a persistently infected BVD carrier) or as part of routine culling 
(for example a subclinical cow infected with MAP). When these approaches are combined with good 
biosecurity measures, it may be possible to achieve freedom of disease. 
 
When a reduction in risk of disease spread is unfeasible it may be prudent to tolerate presence of 
the disease and take steps to increase the rate of cure or limit the severity of disease. This approach 
can only be taken for subclinical diseases where animal welfare is not compromised. Any cattle 
compromised in their welfare by infectious disease should receive prompt treatment or be 
humanely slaughtered.  
 
One option to increase cure and limit disease severity is to improve immune function; this can be 
achieved by reducing stress, providing appropriate nutrition and by breeding animals for increased 
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resistance or resilience to infection (Morris, 2007; Brotherstone et al., 2010). Developments in 
genomics are likely to lead to further discoveries (Bishop and Woolliams, 2014; Raszeck et al, 2016).  
 
Immunity can be stimulated by the use of vaccines. Many cattle vaccines are available, and can limit 
clinical signs and shedding of the infectious pathogen, or reduce the risk of infection, for example by 
limiting foetal infection using a BVD vaccine (Kelling, 2004). However, vaccines must be used 
appropriately to be effective. Vaccination regimes themselves can be complex and errors do occur, 
for example in maintaining the cold chain and in using multiple products at the same time (Cresswell 
et al., 2014). Farmer expectations about the effectiveness of vaccines needs to be carefully managed 
to avoid reliance on vaccination alone; whilst modern vaccines can be very effective, full protection 
is difficult to guarantee in the absence of any other control measures, due to poor compliance, 
insufficient immune response or an overwhelming challenge.  
 
In our example herd, as discussed previously vaccination is being used to limit the potential 
consequences of a BVD incursion. For the diseases already present their impact within the farm also 
needs to be considered. In this herd MAP appears to be present but at a relatively low prevalence. In 
this case the goal may be maintain the low prevalence or ultimately aiming for eradication given the 
farmers aspirations to sell heifers internationally. In this case the biosecurity discussed above still 
applies, buying in a MAP positive bull would not be helpful. However, in this case, the greatest risk is 
the existing infected cows in the herd. The regular quarterly individual cow milk ELISAs provided a 
cost effective method of identifying these cows as early as possible. Then by understanding that 
calves at the highest risk of becoming infected with MAP, control measures can be implemented to 
control this risk of transmission from infected cow to calf. For example, calves born to infected dams 
should not be retained for breeding and positive dams should calve away from the rest of the herd. 
Depending on the number of cows infected, culling might be an easier way to manage the risk they 
pose particularly given the farmers aspirations. If this approach is implemented it would be 
important to warn the farmer that many more positive animals may still be present and continued 
monitoring would be required. 
 
7. Risk communication 
Communication between stakeholders is crucial in infectious disease control and is required at all 
stages of the control process: hazard identification, risk assessment and risk management. Most 
estimates of average animal disease costs in the literature have limited direct application on farm. 
This makes them unsuitable in our communication to farmers. Studies that quote the total cost of 
diseases rather than the avoidable loss exaggerate the benefits of investment in disease prevention 
and may thereby come to lack credibility with farmers. There is also evidence that disease costs are 
positively skewed thus average costs could mask the effects of rare though potentially devastating 
epidemics.  
 
A different picture emerges from studies of animal disease as a source of risk to the dairy farm 
business. Animal disease represents a significant proportion of the risk (relating to variation in farm 
income) over which the dairy farmer has some control. Communication based on risk management 
at farm level, backed by research into the sources of variation in avoidable disease losses therefore 
holds promise. Budgets for interventions to control heifer mastitis were highly dependent on the 
farmer's willingness to pay. Knowing the risk perception of farmers and their rational spending limits 
would be useful for the development of specific interventions to control endemic diseases (Archer et 
al., 2014). 
 
Communication science tells us that influencing behaviour is not simply a question of ‘getting the 
message across’ but of addressing the complex factors that influence an individual’s behavioural 
decisions. There is a diversity of conceptual frameworks to help unravel the complexity of farmer 
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behaviour. Data indicates the difficulties facing those designing communication strategies in a 
context where farmers believe strongly that they are already doing all they can reasonably be 
expected to do to minimise animal health risks. 
 
A way to encourage more consistent compliance with measures might be to focus on risk 
communication, encouraging dairy farmers to develop a more realistic assessment of risk to their 
own animals. This should be tailored to the different disease risk situations faced by different 
farmers, which needs to involve local (public and private) veterinarians who are widely regarded by 
dairy farmers as the main players in interpreting and filtering information emanating from national 
bodies. The farming press could also be used to enhance risk communication, given the wide use and 
credibility of these media in the farming population. 
 
Social science, with its emphasis on social context, has been under-utilised in the exploration of what 
constitutes and creates useful and valued disease risk communication (Fischhoff, 2013; Gilmour et 
al. 2011). Studies show that factors such as gender, education level and age influence how 
prevention and occurrence of disease outbreaks are perceived and best communicated. It is 
invaluable to make efforts to increase knowledge about disease prevention among farmers and 
veterinarians and for veterinarians to be encouraged to motivate farmers to strengthen farm 
biosecurity (Frossling and Noremark, 2016). 
 
The importance of the role of the veterinarian is supported by Richens et al. (2015) who revealed 
that farmers perceive vets to have an important role in facilitating decision-making in all aspects 
surrounding dairy cattle vaccination. This important role was acknowledged by farmers who have 
regular veterinary contact, but also farmers with solely emergency veterinary contact. The individual 
approach to a dairy farm because of its particular characteristics is important and communication 
styles of different stakeholders can be hierarchical, complex and challenging (Enticott, 2008). 
Veterinarians’ perception of their role and communication style can be at odds with farmers’ 
reported preferences (Hall and Wapenaar, 2012). 
 
Differences in farmers’ attitudes have been shown to explain a significant degree of variance in 
mastitis indicators (Jansen et al., 2009) and adapting appropriately to such attitudes is key when 
communicating with that farmer on infectious disease control. Farmers will not act if they do not 
think a problem in serious enough (Jansen et al., 2010b), and this perception of ‘serious’ will vary 
between farmers. Part of this variation is due to prior information or the lack thereof. Although most 
farmers considered biosecurity to be important, 53% stated that a lack of information might prevent 
them from improving their biosecurity (Sayers et al., 2013). This lack of information and knowledge, 
particularly on how to adapt a particular suggestion or piece of advice is a gap that the local 
veterinarian can capitalize on with their particular knowledge of the farm and their infectious 
disease knowledge. 
 
The credibility, of the advice itself, the perceived source of advice or the person or institution giving 
it is vital to the dairy farmer. The science on which recommended measures are based must be 
credible and clearly articulated, and the measures themselves must be seen to be realistic and cost-
effective. The advisor not only needs to be confident about the advice given, the adviser must also 
endeavour to enhance the farmers’ confidence in their ability to implement the advice effectively. 
Training and continuing support of veterinarians and other advisors is of key importance to improve 
infectious disease control on farms. A mastitis control programme in the UK showed that lines of 
communication were important; each user received direct support from a central team, which 
proved to be one of the most important aspects for its success. 
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A mastitis control program in The Netherlands indicated that factors describing a change in the 
farmers’ mind-set influenced the ability to control mastitis on their farm. These factors described a 
change in the perceived lack of control, a change in the perceived lack of influence on sources of 
mastitis, and a change in their concerns about mastitis. To influence that mindset change a 
consistent message from different stakeholders is essential. Research shows particularly at farm 
level that this consistent message is often lacking; communication between advisors and 
veterinarians was sub-optimal with over 60% of each group not being in regular communication with 
each other. 
 
With regards to the main farmer motivation for biosecurity implementation, the majority of 
veterinarians prioritised external factors such as 'economic benefit' and 'mandatory obligation', 
while the majority of advisors prioritised health/animal-related factors, which were similar to those 
of farmers. Inconsistencies in the implementation of and in opinions relating to, farm biosecurity 
were highlighted across all the groups surveyed emphasising the need for standardised evidence 
based information and improved communication (Sayers et al., 2014). To support a consistent 
message, the Countdown programme to control mastitis in Australia targets all advisor groups, and 
does not limit this to veterinarians only (Countdown, 2016). 
 
Table 6 describes a range of methods that can be used to communicate infectious disease risk to 
farmers. Which method to use is situation dependent; a farmer is likely to be more compliant to an 
individual approach to their farm, however, a lack of knowledge holds some farmers back to 
implement changes and therefore combinations with a more general approach is appropriate in 
certain situations. Building a relationship with farmers to identify their mindset as well as identifying 
your own communication style is important and will help decide on the most appropriate 
communication strategy when aiming to control infectious disease on farm. 
 
Table 6. Methods used to communicate infectious disease risk 
 
Oral Written 
Electronic: 
Written 
Post: 
Social media: 
Tailored on farm Email  Newspaper articles Websites 
Advice from professional bodies Government databases Industry leaflets Facebook 
Farmer to farmer Text messaging  Blog 
Conference talks   You tube 
Practice meetings    
Webinars    
(Certified) training courses    
 
 
To optimize communication on the example farm it is important to include all farm employees 
including family members in relevant farm meetings and training. It is advised the veterinarians adds 
time at appropriate routine visits to discuss disease control progress. It may help to identify relevant 
articles in the local farming press to align with the meetings where possible. As the farmer does 
attend discussion groups with peers it is important to get familiar with them; the veterinarian can 
discuss opportunities to contribute to those discussions if infectious diseases are discussed, or show 
interest in what was discussed and evaluate how it aligns with their recommendations. Farm advisors 
should focus on asking open questions, and be credible, i.e. follow-up areas where they are unsure 
about. As the farmer uses other consultants, it is important for the veterinarian to value their advice 
and contact them to initiate collaborations. 
 
8 Ensuring effective Implementation 
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One beacon of successful implementation of an infectious disease control programme is that of 
Rinderpest. After a profound and concerted effort by affected countries, this disease was officially 
declared eradicated in May 2011. The demonstration that by using a cohesive and disciplined 
approach the desired result is achieved can be viewed as a green light to approach other infectious 
diseases of high impact. In the following sections different factors involved in implementation are 
discussed. 
 
Studies have shown that change can be introduced on similar farms with very different results. 
Continuous gradual changes, previous experience with change, inner motivation, deliberate use of 
consultants, and careful planning have a positive impact on farming performance during and after 
change. A key finding is that change should be recognized as a managerial challenge and not only as 
a matter of implementing new technology (Hansen, 2014). The successful management of change is 
crucial for the survival and success of small and medium-sized enterprises, which the majority of 
dairy farms are. Farmers need more than experience of or knowledge about a change to be able to 
succeed. According to Todnem and Dale (2008), motivation is one of eight critical success factors for 
managing organizational change.  
 
Problem-solving skills mean little if a farmer is not motivated to use them. A high degree of 
motivation is required to solve problems in unstructured contexts such as farming because solutions 
require repeated physical efforts. Internal motivated farmers take more actions and explore more 
options than farmers motivated from external forces or opportunities. Internal motivation can be 
influenced by communicative intervention through reasoned opinions, such as articles, study groups 
and discussions. External motivation can be accomplished by financial means such as bonuses and 
penalties related to BMSCC. Motivation rooted in inner interest is stronger and lasts longer than 
motivation due to external forces or opportunities.  
 
Previous work demonstrated that ‘hard to reach’ farmers are not a homogeneous group, but rather 
could be divided into 4 categories based on their trust in external information sources and their 
orientation toward the outside world: ‘proactivists’, ‘do-it-yourselfers’, ‘wait-and-see-ers’, and 
‘reclusive traditionalists’. There is especially much to gain in communication with ‘do-it-yourselfers’ 
and ‘wait-and-see-ers’, but this demands a more proactive role on the part of veterinarians and 
consultants.  
 
Different types of farmers need to be approached in different ways and through different channels 
to help them implement changes (Jansen et al., 2010b). For example, when aiming to improve 
general udder health management, the ‘central route’ (where tools such as instruction cards, 
treatment plans, checklists and software are developed in an argument-based comprehensive way 
and used during on-farm study group meetings for farmers organized by veterinarians and also 
during individual veterinarian–farmer interactions) seemed to be effective if farmers are already 
motivated to optimize their udder health management. For farmers who are less motivated to work 
on udder health, the ‘peripheral route’, using implicit persuasion techniques such as mass media 
campaigns, seemed to be most effective when aiming to change a single management practice 
(Jansen et al., 2010a).  
 
Other work corroborates that farmers’ attitude may be more correlated to animal disease incidence 
than farmers’ behaviour (Kuiper et al., 2005). A study by Nyman et al. (2007) suggested that farmers’ 
attitude towards mastitis and milk production influences the incidence rate of veterinary-treated 
mastitis more than environmental factors such as housing conditions. It is important to be aware of 
individual farmers’ attitudes and goals to be able to influence change. The veterinarian is seen as the 
most trusted person by farmers and plays a key role as source of information for the majority of 
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farmers. The relationship between farmer and veterinarian is of great importance when 
implementing change on farm relating to infectious disease. 
 
Studies looking into the uptake and use of vaccines as a way to control infectious disease in cattle 
indicate there are often practical areas of usage of vaccines which could be improved upon. It is 
important to ensure a consistent approach, so all farm staff needs to be aware of and understand 
the animal health strategy of the farm. It is good practice to have a written procedure on how to 
carry out a task in a controlled and repeatable manner; it includes all requirements to carry out the 
task, including details of process, equipment and materials. Data collection before and after a 
change can provide supporting evidence towards a positive outcome and will be a motivator for 
some farmers to implement change. Nonetheless one needs to appreciate that without a robust and 
appropriate study design it is impossible to prove cause and effect. 
 
Findings suggest that although certain biosecurity practices are undertaken to control infectious 
disease, many are carried out infrequently or not at all. This may be due to many factors, including 
cost (in time and money), lack of proven efficacy of practices and lack of relevant education of 
veterinarians, farmers and other herd health advisors (Brennan et al., 2012). Training, of farmers as 
well as veterinarians and other professionals, is a continuous process and all stakeholders should 
aim for continuous development to be competent to understand the reasoning behind actions. 
 
Think about setting SMART goals when implementing change on farm: 
1. Specific - use numbers or observations from the farm, e.g. reduce the incidence of clinical cases of 
mastitis and the BMSCC.  
2. Measurable - check for improvements or deteriorations, e.g. 50 cases per 100 cows or a BMSCC of 
250,000/ml.  
3. Achievable - be gradual, e.g. reduce mastitis, not eradicate.  
4. Relevant - use objectives that will give you benefit, e.g. get out of the penalty band, and reduce 
the number of milking cow tubes used.  
5. Time based - set realistic targets, e.g. over the next 12 months. 
 
Dependent on the situation, farmers can source support from government or other stakeholder 
groups (levy boards, pedigree associations, retailers, milk processors) to engage the whole sector in 
disease control, and send out a consistent message to the industry and the general public. 
Considerable costs may be incurred in controlling animal diseases, though the control measures paid 
for may not always be effective. This is particularly true for smallholder farmers, who often lack 
information and have limited diagnostic data to base decisions upon. 
 
National or regional control and eradication campaigns require financial support. Total support is 
often given to the control of exotic infectious diseases of major economic importance, such as FMD. 
Sometimes programmes are entirely funded by the farmers such as BVD eradication in Sweden 
(Greiser-Wilke et al., 2003). Financial support can also be given indirectly; through state laboratory 
diagnostic services and participation in herd health schemes. In Israel a proportion of farm insurance 
premiums is directed towards disease control, and in parts of Germany some costs of BVD 
eradication are funded from public animal insurance (Greiser-Wilke et al., 2003). 
 
Control and eradication programmes are more effective when supported by legislation, sometimes 
accompanied by penalties when the legislation is contravened. For example, in Australia and New 
Zealand where rabies is absent, there is legislation forbidding the entry, without quarantine, of 
animals from countries in which the disease is present. The benefits of implementing these 
measures for disease control in agriculture have benefitted the consumer; bTB eradication results in 
milk free of bTB. The culling of infected cows however, represents a financial loss to the farmer, 
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therefore control programmes can include compensation of farmers’ loss of infected animals. In 
other situations, bonuses are offered to increase cooperation of owners; for example awarding a 
bonus to farmers whose bulk milk SCC is below a defined level.  
 
How would the above relate to risk management implementation on our example farm? 
The scenario does not describe the motivation of the farmer in much detail, you will need to ask more 
questions and build a relationship with your client to identify what it is that motivates him. He is clear 
about his goals, and knowing he wants his herd to be as healthy as possible he is likely to be 
receptive to BVD eradication. The quarterly bulk milk monitoring for infectious disease is a good way 
to start the conversation about implementing changes to improve animal health. Presenting the non-
monetary advantages of being disease-free via accredited health schemes may motivate this farmer. 
He vaccinates against BVD, discuss the practicalities of when and how this happens to assess 
compliance and consider adequacy of the protocol. Discuss the fact that disease control is about risk 
reduction, and appreciate that with current farm management (grazing in summer, open sheds) it is 
impossible to eliminate all risk. 
 
Identifying other stakeholders that can support you in making the changes is helpful as he is seeing 
various colleagues and consultants that advise him and he may otherwise be getting inconsistent 
advice. Report your advice briefly in writing so there is a record of what was discussed that he can 
refer to or discuss with others. 
 
9. Trends in infectious disease control strategies 
 
International agencies which play a crucial role in livestock infectious disease control internationally 
include the OIE and FAO of the UN. Their mandates enable them to operate in the international 
arena relatively free from political constraints. There has been increasing interaction with the WHO 
in recent years, partly instigated by the realisation that the majority of new human diseases 
originated from animals. In this context, the term ‘One Health’ has been used to describe the 
collaborative effort of multiple disciplines; working locally, nationally, and globally to attain optimal 
health for people, animals and the environment (Thumbi et al., 2015). 
 
It is helpful to consider the history of disease control in the UK as described by Woods (2011) as an 
example when considering the input from government and other stakeholders in infectious disease 
control. 
 
The highly fatal and contagious disease Rinderpest, whose ravages had prompted the 1865 
formation of a State Veterinary Department in the UK, had last invaded in 1878. With the 
disappearance of epizootic disease, the Veterinary Department turned its attention to two endemic, 
widespread and costly cattle diseases that it judged to be of national importance. Bovine TB and 
brucellosis were of particular concern to dairy farmers and aristocratic pedigree cattle breeders, who 
used their political influence and social connections to lobby for state action. However, doubts 
surrounding diagnostic accuracy, and the time, cost and facilities required for bTB and Brucella 
diagnosis, meant that only a handful of livestock owners were prepared to adopt this practice. Of 
those that agreed to testing, many found it easier to send reacting cattle to market than to isolate 
them. Consequently, the tests contributed to its spread. A 1920 Order to prevent farmers presenting 
cows that had recently aborted for sale in markets proved unenforceable due to the difficulty in 
identifying them. 
 
Another important shaping factor around state responsibility was the consumer politics of milk; a 
nationwide bTB programme failed to succeed, because of the low bonus offered, consumer 
confusion about milk grading, farmers’ distrust of the state, and the unreliability of tuberculin which 
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meant that by 1938, only 3% of herds had achieved attested status. With little faith in—or money to 
pay for—private veterinary aid, farmers responded by slaughtering or selling sick animals and 
replacing them with new ones, so contributing to the spread of disease. 
 
In November 1940, a more successful scheme for the control of certain diseases of dairy cattle 
(brucellosis, infertility, mastitis and MAP), commonly known as the ‘survey’ or ‘panel’ scheme was 
rolled out. Farmers paid a flat fee in return for quarterly visits by practising vets, at which herd 
health and reproductive status were assessed, advice offered and designated treatments performed.  
In 1952, a new organizational structure evolved—the private/public partnership of the dairy cow 
scheme, and had new ends in view: the education of farmers, and to prevent as well as resolve 
disease at the herd level.  
 
These developments enabled the veterinary profession to build a closer relationship with farmers 
and the state, and to develop its expertise and reputation as ‘physician of the farm’. Consequently, 
many veterinary practices became heavily reliant on state work, using it to subsidize their private 
services to farmers. Able to make an ample living from state veterinary work, drug sales and the 
treatment of individual sick animals, the growing body of private vets dispensed with the preventive 
approach of the wartime survey scheme. 
 
This brief history of state veterinary intervention in the UK indicates that scientific knowledge and 
disease demographics do not by themselves explain the shifting boundaries of state responsibility 
for animal health, the diseases targeted and the preferred modes of intervention. Policies were 
shaped by concerns over food security and the public’s health, the state of the national and livestock 
economy, the interests and expertise of the veterinary profession, and prevailing agricultural policy 
where ‘perceptions may have more effect than the pathogens on the policies’. 
 
Many countries are moving towards more industry-led and industry-funded control strategies, often 
in collaboration with government or other stakeholders but with the industry stakeholders taking 
the lead. To retain their disease-free status at EU or WHO level state governments need to perform 
surveillance to demonstrate ‘freedom of disease’. Dependent on country and disease this can be 
done in various ways; monitoring bulk milk samples for Brucella, monitoring blood samples for 
Leptospirosis, monitoring slaughterhouse samples for BSE etc. 
 
Since 1983 the National Animal Health Monitoring System (NAHMS) in the USA has been monitoring 
animal health across the USA. The ability to use this information as a strategic marketing advantage 
is at the centre of domestic and international trade competitiveness. The OIE has developed a world 
animal health information system to monitor and disseminate animal disease information to OIE 
member countries, to alert countries threatened by epidemic outbreaks, to strengthen international 
cooperation on animal disease control and to reduce barriers to the international trade of animal 
and animal products. In Europe, with the introduction of the single market in 1993, all veterinary 
border checks were abolished and free movement of animals became possible through the EU. 
Electronic identification and monitoring systems could be an especially important tool in improving 
collection and subsequent use of information in future animal production.  
 
 
 
 
10. Conclusion 
Infectious diseases in dairy cattle pose threats to food security, food safety, national economies, 
biodiversity and the rural environment. Reliance on treatment with antimicrobials is unlikely to be 
sustainable; therefore the control and prevention of infectious disease in dairy cattle is paramount. 
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Many infectious agents can survive in the environment, and this reservoir can overwhelm host 
defences if hygiene is poor. We acknowledge the importance of maintaining environmental hygiene 
and animal immunity through adequate nutrition and husbandry, but focus on the principals of 
reducing the risk of infectious pathogen transmission by applying a risk analysis approach. This 
includes hazard identification, risk assessment, risk management and risk communication.  The 
framework proposed in this Chapter can be applied to all infectious disease hazards in dairy cattle, 
and examples are provided throughout the Chapter to illustrate this point. 
 
11. Where to look for further information 
Infectious disease hazards in dairy cattle: http://www.oie.int/animal-health-in-the-world/oie-listed-
diseases-2016/. Accessed April 2016.  
 
Infectious disease hazards in dairy cattle: http://www.organicvet.co.uk/Cattleweb/Index.html 
Accessed April 2016.  
 
Infectious disease hazards in dairy cattle: http://www.thecattlesite.com/diseaseinfo/ 
Accessed April 2016.  
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